Nikoletta Fotaki (N Fotaki)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Molecular Docking

Irritable Bowel Syndrome

Top Venues

The AAPS journal

The Journal of pharmacy and pharmacology

AAPS PharmSciTech

This page only lists publications with an associated author ORCID identifier.

Publications

Reveng A Abdulkareem, Aswin Doekhie, Nikoletta Fotaki, Francoise Koumanov, Charlotte A Dodson, Asel Sartbaeva
Thermal Stabilisation of Lysozyme through Ensilication. Molecules (Basel, Switzerland) 29 (17) (2024)
Konstantinos Stamatopoulos, Nena Mistry, Nikoletta Fotaki, David B Turner, Brandon Swift
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor. Pharmaceutics 15 (12) (2023)
Marina Statelova, René Holm, Nikoletta Fotaki, Christos Reppas, Maria Vertzoni
Usefulness of the Beagle Model in the Evaluation of Paracetamol and Ibuprofen Exposure after Oral Administration to Pediatric Populations: An Exploratory Study. Molecular pharmaceutics (2023)
Konstantinos Stamatopoulos, Nena Mistry, Nikoletta Fotaki, David B Turner, Brandon Swift
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor. Pharmaceutics 15 (12) (2023)
Mariana Guimarães, Anil Maharaj, Andrea N Edginton, Maria Vertzoni, Nikoletta Fotaki
Understanding the Impact of Age-Related Changes in Pediatric GI Solubility by Multivariate Data Analysis. Pharmaceutics 14 (2) (2022)
Mariana Guimarães, Pascal Somville, Maria Vertzoni, Nikoletta Fotaki
Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions. The AAPS journal 24 (1) (2022)
Mariana Guimarães, Maria Vertzoni, Nikoletta Fotaki
Performance Evaluation of Montelukast Pediatric Formulations: Part II - a PBPK Modelling Approach. The AAPS journal 24 (1) (2022)
Mariana Guimarães, Martin Kuentz, Maria Vertzoni, Nikoletta Fotaki
Evaluating pediatric and adult simulated fluids solubility: Abraham solvation parameters and multivariate analysis. Pharmaceutical research (2021)
Angela Effinger, Mark McAllister, Irena Tomaszewska, Caitriona M O'Driscoll, Mark Taylor, Steve Gomersall, James Heaton, Kieran L Smith, Inese Sarcevica, Sam L Young, Nikoletta Fotaki
Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal Model. Molecular pharmaceutics 18 (4) (2021)
J Martir, T Flanagan, J Mann, Nikoletta Fotaki
Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance: Part 1-Effects on Solubility of Poorly Soluble Drugs. AAPS PharmSciTech 21 (5) (2020)
Joana Martir, Talia Flanagan, James Mann, Nikoletta Fotaki
Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations. The AAPS journal 22 (2) (2020)
Aleksandra V Bukhovets, Nikoletta Fotaki, Vitaliy V Khutoryanskiy, Rouslan I Moustafine
Interpolymer Complexes of Eudragit® Copolymers as Novel Carriers for Colon-Specific Drug Delivery. Polymers 12 (7) (2020)
P Zarmpi, T Flanagan, E Meehan, J Mann, Nikoletta Fotaki
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC). The AAPS journal 22 (2) (2020)
J Martir, T Flanagan, J Mann, Nikoletta Fotaki
In Vivo Predictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants. AAPS PharmSciTech 21 (7) (2020)
Panagiota Zarmpi, Talia Flanagan, Elizabeth Meehan, James Mann, Nikoletta Fotaki
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants. The AAPS journal 22 (2) (2020)
J Martir, T Flanagan, J Mann, Nikoletta Fotaki
Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations. AAPS PharmSciTech 21 (7) (2020)
Ioannis Loisios-Konstantinidis, Rafael L M Paraiso, Nikoletta Fotaki, Mark McAllister, Rodrigo Cristofoletti, Jennifer Dressman
Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2019)
Anna C Van der Vossen, Lidwien M Hanff, Arnold G Vulto, Nikoletta Fotaki
Potential prediction of formulation performance in paediatric patients using biopharmaceutical tools and simulation of clinically relevant administration scenarios of nifedipine and lorazepam. British journal of clinical pharmacology 85 (8) (2019)
Chara Litou, Angela Effinger, Edmund S Kostewicz, Karl J Box, Nikoletta Fotaki, Jennifer B Dressman
Effects of medicines used to treat gastrointestinal diseases on the pharmacokinetics of coadministered drugs: a PEARRL Review. The Journal of pharmacy and pharmacology 71 (4) (2018)
Angela Effinger, Caitriona M O'Driscoll, Mark McAllister, Nikoletta Fotaki
Impact of gastrointestinal disease states on oral drug absorption - implications for formulation design - a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2018)
Mariana Guimarães, Marina Statelova, René Holm, Christos Reppas, Moira Symilllides, Maria Vertzoni, Nikoletta Fotaki
Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products - a PEARRL review. The Journal of pharmacy and pharmacology 71 (4) (2018)